Table: Garna Biosciences -2022 group results

Carna Biosciences

27/03/2023 01:00

Mar 27 (Reuters)- 
          Garna Biosciences Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to         NEXT   
              Dec 31, 2022    Dec 31, 2021     Dec 31, 2023      YEAR     
                 LATEST         YEAR-AGO         COMPANY        COMPANY   
                 RESULTS         RESULTS         FORECAST     H1 FORECAST 
  Sales           1.39            2.02           902 mln                  
               (-31.3 pct)     (+78.0 pct)     (-34.9 pct)                
  Operating     loss 1.27     loss 531 mln      loss 1.89                 
  Recurring     loss 1.28     loss 522 mln      loss 1.91                 
  Net
  Net           loss 1.35     loss 534 mln      loss 1.94                 
  EPS        loss 99.10 yen  loss 42.10 yen  loss 125.25 yen              
  Ann Div          NIL             NIL             NIL                    
  -Q2 Div          NIL             NIL             NIL                    
  -Q4 Div          NIL             NIL             NIL                    
  
  NOTE - Garna Biosciences Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T